Tags: epilepsy | drug | lundbeck | sabril

Epilepsy Treatment for Kids

Danish pharmaceutical group Lundbeck has won approval in the United States of its epilepsy drug, Sabril, to be used in children aged 10 years and older.
 
Lundbeck said in a statement the United States Food and Drug Administration (FDA) had approved Sabril as an add-on therapy for the treatment of refractory complex partial seizures in children who have inadequately responded to several other treatments.

© 2015 Thomson/Reuters. All rights reserved.

1Like our page
2Share
FDA-Approved-Drugs
Lundbeck has won approval in the United States of its epilepsy drug, Sabril, to be used in children aged 10 years and older.
epilepsy,drug,lundbeck,sabril
64
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved